{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T16:22:34Z","timestamp":1776356554603,"version":"3.51.2"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.neuropharm.2014.06.014","type":"journal-article","created":{"date-parts":[[2014,6,18]],"date-time":"2014-06-18T11:23:53Z","timestamp":1403090633000},"page":"161-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["The use of stimulant medications for non-core aspects of ADHD and in other disorders"],"prefix":"10.1016","volume":"87","author":[{"given":"Eugenia","family":"Sinita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Coghill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2014.06.014_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/mds.10390","article-title":"Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease","volume":"18","author":"Adler","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib2","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1176\/appi.ajp.158.5.818-a","article-title":"Adderall for obsessive-compulsive disorder","volume":"158","author":"Albucher","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib3","first-page":"816","article-title":"Methylphenidate and thioridazine in the treatment of intellectually subaverage children: effects on cognitive-motor performance","volume":"30","author":"Aman","year":"1991","journal-title":"J.\u00a0Am. Acad. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2009.04.015","article-title":"Modafinil for the treatment of cocaine dependence","volume":"104","author":"Anderson","year":"2009","journal-title":"Drug. Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00787-006-0549-0","article-title":"Long-acting medications for the hyperkinetic disorders: a systematic review and European treatment guideline","volume":"15","author":"Banaschewski","year":"2006","journal-title":"Eur. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib6","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0278-5846(88)90014-0","article-title":"Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil","volume":"12","author":"Bastuji","year":"1988","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/088307389701200405","article-title":"Treatment of children with Williams syndrome with methylphenidate","volume":"12","author":"Bawden","year":"1997","journal-title":"J.\u00a0Child. Neurol."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00213-003-1508-9","article-title":"Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy","volume":"171","author":"Becker","year":"2004","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2165\/00002512-200522020-00006","article-title":"Poststroke aphasia : epidemiology, pathophysiology and treatment","volume":"22","author":"Berthier","year":"2005","journal-title":"Drugs Aging"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/sleep\/22.6.757","article-title":"Health-related quality of life effects of modafinil for treatment of narcolepsy","volume":"22","author":"Beusterien","year":"1999","journal-title":"Sleep"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jpeds.2007.07.052","article-title":"Modafinil improves symptoms of attention-deficit\/hyperactivity disorder across subtypes in children and adolescents","volume":"152","author":"Biederman","year":"2008","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib12","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/CHI.0b013e3181b26e9f","article-title":"Meta-analysis: treatment of attention-deficit\/hyperactivity disorder in children with comorbid tic disorders","volume":"48","author":"Bloch","year":"2009","journal-title":"J.\u00a0Am. Acad. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2005.07.047","article-title":"Does methylphenidate reduce the symptoms of chronic fatigue syndrome?","volume":"119","author":"Blockmans","year":"2006","journal-title":"Am. J. Med."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib14","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.clinthera.2010.02.011","volume":"32","author":"Boellner","year":"2010","journal-title":"Clin. Ther."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/0269881113519509","article-title":"Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology","volume":"28","author":"Bolea-Alamanac","year":"2014","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib16","first-page":"67","article-title":"Methylphenidate associated with narcotics for the treatment of cancer pain","volume":"71","author":"Bruera","year":"1987","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib17","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1200\/JCO.2003.06.156","article-title":"Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report","volume":"21","author":"Bruera","year":"2003","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib18","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.ijrobp.2007.05.076","article-title":"A\u00a0phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy","volume":"69","author":"Butler","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib19","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/jnnp.52.6.724","article-title":"Major depression in Parkinson's disease and the mood response to intravenous methylphenidate: possible role of the \u201chedonic\u201d dopamine synapse","volume":"52","author":"Cantello","year":"1989","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib20","article-title":"Stimulant ADHD medication and risk for substance abuse","author":"Chang","year":"2013","journal-title":"J.\u00a0Child. Psychol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1087054712448252","article-title":"The effects of lisdexamfetamine dimesylate on emotional lability in children 6 to 12 years of age with ADHD in a double-blind placebo-controlled trial","volume":"18","author":"Childress","year":"2014","journal-title":"J.\u00a0Atten. Disord."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib22","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.euroneuro.2012.11.012","article-title":"European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit\/hyperactivity disorder","volume":"23","author":"Coghill","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib23","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.biopsych.2006.12.030","article-title":"The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit\/hyperactivity disorder","volume":"62","author":"Coghill","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/jcpp.12036","article-title":"Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents","volume":"54","author":"Cortese","year":"2013","journal-title":"J.\u00a0Child. Psychol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib25","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1017\/S0033291713000676","article-title":"Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory","volume":"44","author":"Cubillo","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jsat.2011.12.014","article-title":"A\u00a0double-blind, placebo-controlled trial of modafinil for cocaine dependence","volume":"43","author":"Dackis","year":"2012","journal-title":"J.\u00a0Subst. Abuse Treat."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib27","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1212\/WNL.56.6.794","article-title":"Modafinil for excessive daytime sleepiness in myotonic dystrophy","volume":"56","author":"Damian","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/01.jcp.0000104910.75206.b9","article-title":"A\u00a0prospective trial of modafinil as an adjunctive treatment of major depression","volume":"24","author":"DeBattista","year":"2004","journal-title":"J.\u00a0Clinical Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib29","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s40263-013-0104-8","article-title":"Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit\/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study","volume":"27","author":"Dittmann","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib30","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40261-013-0073-1","article-title":"An open-label investigation of the pharmacokinetic profiles of lisdexamfetamine dimesylate and venlafaxine extended-release, administered alone and in combination, in healthy adults","volume":"33","author":"Ermer","year":"2013","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib31","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1176\/ajp.130.8.922","article-title":"Methylphenidate in tardive dyskinesia","volume":"130","author":"Fann","year":"1973","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib32","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1212\/WNL.0b013e3181b23551","article-title":"Neuropsychological status at seizure onset in children: risk factors for early cognitive deficits","volume":"73","author":"Fastenau","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4088\/JCP.v66n0112","article-title":"A\u00a0multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness","volume":"66","author":"Fava","year":"2005","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib34","first-page":"1081","article-title":"Methylphenidate in children with seizures and attention-deficit disorder","volume":"143","author":"Feldman","year":"1989","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib35","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0033-3182(87)72476-1","article-title":"Methylphenidate for depressive disorders in cancer patients. An alternative to standard antidepressants","volume":"28","author":"Fernandez","year":"1987","journal-title":"Psychosomatics"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib36","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/syn.20111","article-title":"Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: a dual probe microdialysis study in awake rat","volume":"55","author":"Ferraro","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib37","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.4088\/JCP.08m04683","article-title":"Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial","volume":"70","author":"Freudenreich","year":"2009","journal-title":"J.\u00a0Clinical Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12402-010-0025-z","article-title":"The mixed amphetamine salt extended release (Adderall XR, Max-XR) as an adjunctive to SSRIS or SNRIS in the treatment of adult ADHD patients with comorbid partially responsive generalized anxiety: an open-label study","volume":"2","author":"Gabriel","year":"2010","journal-title":"Atten. Defic. Hyperact. Disord."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib39","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archpsyc.56.4.330","article-title":"Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder","volume":"56","author":"Gadow","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib40","first-page":"100","article-title":"Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study","volume":"30","author":"Gagnon","year":"2005","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1176\/jnp.9.2.231","article-title":"Methylphenidate treatment of negative symptoms in patients with dementia","volume":"9","author":"Galynker","year":"1997","journal-title":"J.\u00a0Neuropsychiatry Clinical Neurosciences"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib42","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.apmr.2005.08.114","article-title":"Applying the clinical practice improvement approach to stroke rehabilitation: methods used and baseline results","volume":"86","author":"Gassaway","year":"2005","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib43","first-page":"349","article-title":"Mechanisms of modafinil: a review of current research","volume":"3","author":"Gerrard","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib44","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0003-9993(98)90169-1","article-title":"Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study","volume":"79","author":"Grade","year":"1998","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00787-010-0140-6","article-title":"European guidelines on managing adverse effects of medication for ADHD","volume":"20","author":"Graham","year":"2011","journal-title":"Eur. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib46","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2165\/00023210-200822030-00003","article-title":"Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management","volume":"22","author":"Graham","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib47","doi-asserted-by":"crossref","first-page":"26s","DOI":"10.1097\/00004583-200202001-00003","article-title":"Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults","volume":"41","author":"Greenhill","year":"2002","journal-title":"J.\u00a0Am. Acad. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib48","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/00004583-200111000-00020","article-title":"Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults","volume":"40","author":"Greenhill","year":"2001","journal-title":"J.\u00a0Am. Acad. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib49","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0022-3476(97)70258-0","article-title":"Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective?","volume":"130","author":"Gross-Tsur","year":"1997","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/08830738030180020601","article-title":"Use of methylphenidate for attention-deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities","volume":"18","author":"Gucuyener","year":"2003","journal-title":"J.\u00a0Child Neurol.y"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib51","first-page":"632","article-title":"Successful treatment of excessive daytime sleepiness in Parkinson's disease with modafinil","volume":"248","author":"Happe","year":"2001","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib52","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.npp.1301472","article-title":"Smoked cocaine self-administration is decreased by modafinil","volume":"33","author":"Hart","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib53","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/0269881113482532","article-title":"Amphetamine, past and present\u2013a pharmacological and clinical perspective","volume":"27","author":"Heal","year":"2013","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib54","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/104990910101800610","article-title":"A\u00a0phase II study of methylphenidate for depression in advanced cancer","volume":"18","author":"Homsi","year":"2001","journal-title":"Am. J. Hosp. Palliat. Care"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib55","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1001\/jamapsychiatry.2013.1273","article-title":"Stimulant medication and substance use outcomes: a meta-analysis","volume":"70","author":"Humphreys","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib56","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1176\/ajp.2006.163.12.2184","article-title":"Impact of modafinil on prefrontal executive function in schizophrenia","volume":"163","author":"Hunter","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib57","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/088307380201700303","article-title":"Use of modafinil in spastic cerebral palsy","volume":"17","author":"Hurst","year":"2002","journal-title":"J.\u00a0Child. Neurol."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib58","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10803-008-0636-9","article-title":"Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity","volume":"39","author":"Jahromi","year":"2009","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib59","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/archpsyc.1976.01770030024003","article-title":"Methylphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms","volume":"33","author":"Janowsky","year":"1976","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib60","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2036.2006.03223.x","article-title":"An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis","volume":"25","author":"Jones","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib61","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1126\/science.163.3862.32","article-title":"Biogenic amines and the states of sleep","author":"Jouvet","year":"1969","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib62","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.psychres.2008.06.024","article-title":"A\u00a0randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder","volume":"168","author":"Kahbazi","year":"2009","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib63","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1212\/WNL.0b013e3181fd62a2","article-title":"Modafinil ameliorates excessive daytime sleepiness after traumatic brain injury","volume":"75","author":"Kaiser","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib64","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00004583-199009000-00007","article-title":"Effects of methylphenidate on adolescents with aggressive conduct disorder and ADDH: a preliminary report","volume":"29","author":"Kaplan","year":"1990","journal-title":"J.\u00a0Am. Acad. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib65","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1177\/1087054710389990","article-title":"Clinically relevant changes in emotional expression in children with ADHD treated with lisdexamfetamine dimesylate","volume":"16","author":"Katic","year":"2012","journal-title":"J.\u00a0Attention Disorders"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib66","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1176\/ajp.137.8.963","article-title":"Treatment of depression in the medically ill elderly with methylphenidate","volume":"137","author":"Katon","year":"1980","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib67","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/1568015033357751","article-title":"The therapeutic potential of amphetamines in Post-stroke recovery","volume":"3","author":"Khokar","year":"2003","journal-title":"Curr. Med. Chem. -Central Nerv. Syst. Agent"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib68","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1002\/cncr.24287","article-title":"The effect of modafinil on cognitive function in breast cancer survivors","volume":"115","author":"Kohli","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib69","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/1087054712440320","article-title":"A\u00a0pilot study of lis-dexamfetamine dimesylate (LDX\/SPD489) to facilitate smoking cessation in nicotine-dependent adults with ADHD","volume":"18","author":"Kollins","year":"2014","journal-title":"J.\u00a0Atten. Disord."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib70","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1590\/S0004-282X2010000100023","article-title":"Attention deficit and hyperactivity disorder in people with epilepsy: diagnosis and implications to the treatment","volume":"68","author":"Koneski","year":"2010","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib71","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.yebeh.2011.02.029","article-title":"Efficacy and safety of methylphenidate in treating ADHD symptoms in children and adolescents with uncontrolled seizures: a Brazilian sample study and literature review","volume":"21","author":"Koneski","year":"2011","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib72","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.2165\/00003495-200868130-00003","article-title":"Approved and investigational uses of modafinil: an evidence-based review","volume":"68","author":"Kumar","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib73","first-page":"645","article-title":"Modafinil effects in multiple sclerosis patients with fatigue","volume":"256","author":"Lange","year":"2009","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib74","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1038\/npp.2013.111","article-title":"Adjunctive lisdexamfetamine dimesylate therapy in adult outpatients with predominant negative symptoms of schizophrenia: open-label and randomized-withdrawal phases","volume":"38","author":"Lasser","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib75","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.4088\/JCP.v64n1202","article-title":"Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: an open trial","volume":"64","author":"Lavretsky","year":"2003","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib76","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/00019442-200108000-00015","article-title":"Methylphenidate augmentation of citalopram in elderly depressed patients","volume":"9","author":"Lavretsky","year":"2001","journal-title":"Am. Journal Geriatric Psychiatry: Official Journal Am. Assoc. Geriatric Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib77","first-page":"447","article-title":"Efficacy and side effects of methylphenidate for poststroke depression","volume":"53","author":"Lazarus","year":"1992","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib78","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hup.668","article-title":"Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury","volume":"20","author":"Lee","year":"2005","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib79","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.drugalcdep.2006.07.004","article-title":"Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo","volume":"87","author":"Levin","year":"2007","journal-title":"Drug. Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib80","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4088\/JCP.v59n0605","article-title":"Methylphenidate treatment for cocaine abusers with adult attention-deficit\/hyperactivity disorder: a pilot study","volume":"59","author":"Levin","year":"1998","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib81","first-page":"151","article-title":"Methylphenidate in treating poststroke depression","volume":"49","author":"Lingam","year":"1988","journal-title":"J.\u00a0Clinical Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib82","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0165-0327(03)00162-9","article-title":"Modafinil treatment in patients with seasonal affective disorder\/winter depression: an open-label pilot study","volume":"81","author":"Lundt","year":"2004","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib83","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1212\/01.WNL.0000037481.08283.51","article-title":"Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy","volume":"59","author":"MacDonald","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib84","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4088\/JCP.v64n0420h","article-title":"Three case reports of modafinil use in treating sedation induced by antipsychotic medications","volume":"64","author":"Makela","year":"2003","journal-title":"J.\u00a0Clinical Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib85","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/hup.2325","article-title":"The effect of lisdexamfetamine dimesylate on body weight, metabolic parameters, and attention deficit hyperactivity disorder symptomatology in adults with bipolar I\/II disorder","volume":"28","author":"McIntyre","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib86","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1002\/mds.21656","article-title":"Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial","volume":"22","author":"Mendonca","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib87","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4088\/JCP.v61n0510","article-title":"Modafinil augmentation of antidepressant treatment in depression","volume":"61","author":"Menza","year":"2000","journal-title":"J.\u00a0Clinical Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib88","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1200\/JCO.1998.16.7.2522","article-title":"Methylphenidate therapy improves cognition, mood, and function of brain tumor patients","volume":"16","author":"Meyers","year":"1998","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib89","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/sleep\/9.1.260","article-title":"Treatment of narcolepsy: objective studies on methylphenidate, pemoline, and protriptyline","volume":"9","author":"Mitler","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib90","first-page":"153","article-title":"Effect of methylphenidate on brain injury-related anger","volume":"74","author":"Mooney","year":"1993","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib91","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1006\/ebeh.2001.0313","article-title":"An evaluation of the effects of methylphenidate on outcomes in adult epilepsy patients","volume":"3","author":"Moore","year":"2002","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib92","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/schbul\/sbm090","article-title":"A\u00a0review of the effects of modafinil on cognition in schizophrenia","volume":"33","author":"Morein-Zamir","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib93","first-page":"489","article-title":"Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study","volume":"260","author":"Morrow","year":"2013","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib94","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1200\/JCO.2004.04.128","article-title":"Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer","volume":"22","author":"Mulhern","year":"2004","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib95","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00787-013-0386-x","article-title":"An inventory of European data sources for the long-term safety evaluation of methylphenidate","volume":"22","author":"Murray","year":"2013","journal-title":"Eur. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib96","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0269881106073219","article-title":"Evidence-based guidelines for management of attention-deficit\/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology","volume":"21","author":"Nutt","year":"2007","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib97","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1176\/appi.psy.44.1.38","article-title":"A\u00a0pilot randomized controlled trial of dexamphetamine in patients with chronic fatigue syndrome","volume":"44","author":"Olson","year":"2003","journal-title":"Psychosomatics"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib98","article-title":"Psychostimulants in depression","volume":"239","author":"Patra","year":"2012","journal-title":"Maudsley Prescr. Guidel. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib99","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0003-9993(96)90291-9","article-title":"Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study","volume":"77","author":"Plenger","year":"1996","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib100","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.biopsych.2006.09.028","article-title":"Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures","volume":"61","author":"Posey","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib101","first-page":"CD007990","article-title":"Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders","author":"Pringsheim","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib102","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF02179289","article-title":"Use of methylphenidate in the treatment of children with autistic disorder","volume":"25","author":"Quintana","year":"1995","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib103","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mus.21245","article-title":"Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study","volume":"39","author":"Rabkin","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib104","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.npp.1300886","article-title":"Methylphenidate (\u2018Ritalin\u2019) can ameliorate abnormal risk-taking behavior in the frontal variant of frontotemporal dementia","volume":"31","author":"Rahman","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/jnnp.72.2.179","article-title":"Efficacy and safety of modafinil (Provigil\u00ae) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study","volume":"72","author":"Rammohan","year":"2002","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib106","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/0269881105056531","article-title":"Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndrome","volume":"19","author":"Randall","year":"2005","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib107","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4088\/JCP.v69n0112","article-title":"Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial","volume":"69","author":"Ravindran","year":"2008","journal-title":"J.\u00a0Clinical Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib108","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tics.2011.11.009","article-title":"Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry","volume":"16","author":"Robbins","year":"2012","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib109","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00787-011-0163-7","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment","volume":"20","author":"Roessner","year":"2011","journal-title":"Eur. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib110","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1017\/S0012162206001290","article-title":"First-onset tics in patients with attention-deficit-hyperactivity disorder: impact of stimulants","volume":"48","author":"Roessner","year":"2006","journal-title":"Dev. Med. Child. Neurol."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib111","first-page":"263","article-title":"Methylphenidate in depressed medically ill patients","volume":"52","author":"Rosenberg","year":"1991","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib112","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3109\/15622971003624197","article-title":"Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD","volume":"11","author":"Rosler","year":"2010","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib113","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1176\/ajp.2006.163.7.1149","article-title":"Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder","volume":"163","author":"Ross","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib114","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/archpsyc.62.11.1266","article-title":"Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity","volume":"62","author":"RUPPAN","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4088\/JCP.07r03982","article-title":"Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review","volume":"70","author":"Saavedra-Velez","year":"2009","journal-title":"J.\u00a0Clinical Psychiatry"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2014.06.014_bib116","doi-asserted-by":"crossref","first-page":"I27","DOI":"10.1007\/s007870070017","article-title":"Stimulant drugs","volume":"9","author":"Santosh","year":"2000","journal-title":"Eur. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib117","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/104990910101800310","article-title":"Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study","volume":"18","author":"Sarhill","year":"2001","journal-title":"Am. J. Hosp. Palliat. Care"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib118","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/(SICI)1098-108X(199704)21:3<299::AID-EAT11>3.0.CO;2-W","article-title":"Efficacy of methylphenidate in bulimia nervosa comorbid with attention-deficit hyperactivity disorder: a case report","volume":"21","author":"Schweickert","year":"1997","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib119","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1469-7610.2012.02569.x","article-title":"Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability","volume":"54","author":"Simonoff","year":"2013","journal-title":"J.\u00a0Child. Psychol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib120","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/(SICI)1098-108X(199903)25:2<233::AID-EAT14>3.0.CO;2-2","article-title":"Methylphenidate treatment for bulimia nervosa associated with a cluster B personality disorder","volume":"25","author":"Sokol","year":"1999","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib121","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-0404.2006.00728.x","article-title":"Effects of amphetamine and\/or l-dopa and physiotherapy after stroke \u2013 a blinded randomized study","volume":"115","author":"Sonde","year":"2007","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib122","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000047712","article-title":"A\u00a0double-blind placebo-controlled study of the effects of amphetamine and physiotherapy after stroke","volume":"12","author":"Sonde","year":"2001","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib123","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/0269216309102614","article-title":"Modafinil for the treatment of fatigue in lung cancer: a pilot study","volume":"23","author":"Spathis","year":"2009","journal-title":"Palliat. Med."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib124","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/02699059309034959","article-title":"A\u00a0double-blind controlled study of methylphenidate treatment in closed head injury","volume":"7","author":"Speech","year":"1993","journal-title":"Brain Inj."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib125","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1192\/bjp.187.1.55","article-title":"Modafinil modulates anterior cingulate function in chronic schizophrenia","volume":"187","author":"Spence","year":"2005","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib126","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1212\/01.WNL.0000158272.27070.6A","article-title":"Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study","volume":"64","author":"Stankoff","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib127","first-page":"72","article-title":"Methylphenidate augmentation of serotonin selective reuptake inhibitors: a case series","volume":"57","author":"Stoll","year":"1996","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib128","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/cap.2000.10.311","article-title":"Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults","volume":"10","author":"Taylor","year":"2000","journal-title":"J.\u00a0Child. Adolesc. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib129","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1017\/S1092852900010622","article-title":"Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study","volume":"11","author":"Thase","year":"2006","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib130","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1089\/cap.2004.14.448","article-title":"Stimulant drug treatment in childhood-onset schizophrenia with comorbid ADHD: an open-label case series","volume":"14","author":"Tossell","year":"2004","journal-title":"J.\u00a0Child. Adolesc. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib131","doi-asserted-by":"crossref","first-page":"802","DOI":"10.4088\/JCP.13m08360","article-title":"A\u00a0randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram","volume":"74","author":"Trivedi","year":"2013","journal-title":"J.\u00a0Clinical Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib132","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.biopsych.2004.02.008","article-title":"Modafinil improves cognition and response inhibition in adult attention-deficit\/hyperactivity disorder","volume":"55","author":"Turner","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib133","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/sj.npp.1300457","article-title":"Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia","volume":"29","author":"Turner","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib134","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00213-003-1457-3","article-title":"Relative lack of cognitive effects of methylphenidate in elderly male volunteers","volume":"168","author":"Turner","year":"2003","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib135","first-page":"452","article-title":"Modafinil for Parkinson's disease fatigue","volume":"257","author":"Tyne","year":"2010","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib136","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ana.410430115","article-title":"Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group","volume":"43","author":"USMNMSG","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib137","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1212\/01.wnl.0000261912.53959.b4","article-title":"Modafinil for treatment of fatigue in post-polio syndrome: a randomized controlled trial","volume":"68","author":"Vasconcelos","year":"2007","journal-title":"Neurology"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2014.06.014_bib138","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1177\/070674370200601S05","article-title":"Mechanism of action of methylphenidate: insights from PET imaging studies","volume":"6","author":"Volkow","year":"2002","journal-title":"J.\u00a0Atten. Disord."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib139","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4088\/JCP.v61n0608","article-title":"Effects of dextroamphetamine on depression and fatigue in men with HIV: a double-blind, placebo-controlled trial","volume":"61","author":"Wagner","year":"2000","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib140","first-page":"251","article-title":"Amphetamine and post-stroke rehabilitation: indications and controversies","volume":"49","author":"Walker-Batson","year":"2013","journal-title":"Eur. J. Phys. Rehabil. Med."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib141","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1161\/hs0901.095720","article-title":"A\u00a0double-blind, placebo-controlled study of the use of amphetamine in the treatment of aphasia","volume":"32","author":"Walker-Batson","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib142","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1161\/01.STR.26.12.2254","article-title":"Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence","volume":"26","author":"Walker-Batson","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib143","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1526-4637.2003.03014.x","article-title":"Modafinil treatment of opioid-induced sedation","volume":"4","author":"Webster","year":"2003","journal-title":"Pain Med."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib144","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4088\/JCP.v67n0412","article-title":"A\u00a0randomized double-blind trial of paroxetine and\/or dextroamphetamine and problem-focused therapy for attention-deficit\/hyperactivity disorder in adults","volume":"67","author":"Weiss","year":"2006","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib145","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1469-8749.2007.00498.x","article-title":"Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine","volume":"49","author":"Wernicke","year":"2007","journal-title":"Dev. Med. Child. Neurol."},{"key":"10.1016\/j.neuropharm.2014.06.014_bib146","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1176\/ajp.127.12.1619","article-title":"A\u00a0potential clinical use for methylphenidate with tricyclic antidepressants","volume":"127","author":"Wharton","year":"1971","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib147","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1087054710378008","article-title":"Reading performance as a function of treatment with lisdexamfetamine dimesylate in elementary school children diagnosed with ADHD","volume":"16","author":"Wigal","year":"2012","journal-title":"J.\u00a0Attention Disorders"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib148","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1542\/peds.111.1.179","article-title":"Does stimulant therapy of attention-deficit\/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature","volume":"111","author":"Wilens","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib149","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00365854","article-title":"A\u00a0randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics","volume":"3","author":"Wilwerding","year":"1995","journal-title":"Supportive Care Cancer"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib150","first-page":"86","article-title":"Methylphenidate and seizure frequency in brain injured patients with seizure disorders","volume":"53","author":"Wroblewski","year":"1992","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib151","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.psychres.2012.09.007","article-title":"Use of lisdexamfetamine dimesylate in treatment of executive functioning deficits and chronic fatigue syndrome: a double blind, placebo-controlled study","volume":"207","author":"Young","year":"2013","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.neuropharm.2014.06.014_bib152","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1310\/2403-B0CY-1UDN-4B6D","article-title":"Neurostimulant medication usage during stroke rehabilitation: the Post-Stroke Rehabilitation Outcomes Project (PSROP)","volume":"12","author":"Zorowitz","year":"2005","journal-title":"Top. Stroke Rehabil."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814002366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814002366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T17:02:53Z","timestamp":1565542973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390814002366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":152,"alternative-id":["S0028390814002366"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.06.014","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of stimulant medications for non-core aspects of ADHD and in other disorders","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}